Clinical Trials on Sports Nutrition in Portugal

Total 396 results

Bial - Portela C S.A.

Completed

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of Food on BIA 6-512 (Trans-resveratrol)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. (BIPARKII)

Parkinson's Disease

Portugal
University of Minho
Foundation for Science and Technology, Portugal

Completed

Relaxation Intervention in Patients With Diabetic Foot Ulcer

Diabetes Mellitus | Diabetic Foot Ulcer

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Hospital de Sao Sebastiao
Instituto de Ciências Biomédicas Abel Salazar; The Novo Nordisk Foundation...

Active, not recruiting

Surgical Innovation for Diabetes Treatment (SURIDIAB-1)

Obesity | Diabetes Mellitus, Type 2

Portugal
Bial - Portela C S.A.

Terminated

Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain

Painful Diabetic Neuropathy

Portugal
University of Minho
Foundation for Science and Technology, Portugal

Completed

Contribution of Psychological Factors in the Healing of the Diabetic Foot Ulcer

Diabetes Mellitus | Diabetic Foot Ulcer

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Parkinson's Disease (PD)

Portugal
Bial - Portela C S.A.

Completed

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Parkinson's Disease

Portugal, Romania, Ukraine
Escola Superior de Tecnologia da Saúde do Porto

Completed

Effects of Microcurrent in a Cardiovascular Rehabilitation Home-based Program

Acute Myocardial Infarction

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Tiina Maarit Andersen
Haukeland University Hospital; Universidade do Porto; University of Trás-os-Montes...

Enrolling by invitation

Systematic Laryngoscopic Evaluation of Upper Airways in Ventilated ALS Patients in Portugal and in Norway

Amyotrophic Lateral Sclerosis

Norway, Portugal
Association for Innovation and Biomedical Research...

Completed

Biomarkers of Diabetic Retinopathy Progression (C-Tracer)

Type 2 Diabetes Mellitus | Mild Nonproliferative Diabetic Retinopathy

Portugal, India
Pennington Biomedical Research Center
The Coca-Cola Company

Completed

International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE)

Childhood Obesity

United States, Australia, Brazil, Canada, China, Colombia, Finland, India, Kenya, Portugal, South Africa, United Kingdom
ClinTrio Ltd.

Unknown

Banded Versus Conventional Laparoscopic Roux-en-Y (GABY) (GABY)

Morbid Obesity Requiring Bariatric Surgery

Belgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
Hospital de Sao Sebastiao
Instituto de Ciências Biomédicas Abel Salazar; The Novo Nordisk Foundation...

Recruiting

Surgical Innovation for Diabetes Treatment 2 (SURIDIAB2)

Enteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric Procedures | Determine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the Superobese | Determine Whether or Not Revision...

Portugal
Alnylam Pharmaceuticals

Completed

Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis

Transthyretin Mediated Amyloidosis (ATTR)

United Kingdom, France, Portugal, Sweden
AstraZeneca

Completed

Better Diabetes Control, Quality - Educate to Achieve Compliance. (MINERVA)

Diabetes Type 2

Portugal
Juvantia Pharma Ltd
Santhera Pharmaceuticals

Unknown

Fipamezole in Neurogenic Orthostatic Hypotension (Foehn)

Parkinson's Disease | Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension (NOH)

France, Portugal
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Active, not recruiting

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART) (CHART)

Diabetes Mellitus, Type 2 | Retinal Disease | NPDR - Non Proliferative Diabetic Retinopathy

France, Italy, Portugal
Inventiva Pharma

Completed

A Study in MPS VI to Assess Safety and Efficacy of Odiparcil (iMProveS)

Mucopolysaccharidosis VI

United Kingdom, France, Germany, Portugal
Novo Nordisk A/S

Active, not recruiting

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

Obesity

United States, Belgium, Malaysia, Portugal, Russian Federation, Switzerland, India, Israel, Mexico
Centre National de la Recherche Scientifique, France
Instituto de Medicina Molecular João Lobo Antunes

Unknown

Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison (FraLusoPark)

Disease Progression | Parkinson's Disease | Dysarthria | Speech | Medical Treatment | Cross-language

France, Portugal
Novo Nordisk A/S

Completed

Changing Diabetes® World Tour

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United Arab Emirates, Saudi Arabia, Portugal
Gene PreDiT
Blueclinical, Ltd.

Terminated

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects (GPD-01-01)

Obesity

Portugal
BioMarin Pharmaceutical

Completed

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

Mucopolysaccharidosis VI | Maroteaux-Lamy Syndrome

United States, Portugal, France
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (STEP 4)

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
Prothena Biosciences Limited

Terminated

A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

Amyloidogenic Transthyretin (ATTR) Amyloidosis

United States, Spain, Sweden, Portugal
NeuraLight
European Clinical Research Infrastructure Network

Recruiting

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease (PALOMA)

Parkinson Disease

United States, Switzerland, Portugal, United Kingdom, Spain
Abbott Products

Terminated

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

Advanced Stage Parkinson's Disease

Germany, Italy, Portugal
Novo Nordisk A/S

Recruiting

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight (STEP Young)

Obesity

Belgium, United Kingdom, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico, Denmark
University College, London
Lund University; University Hospital, Bordeaux; Ludwig-Maximilians - University... and other collaborators

Completed

Care for Late Stage Parkinsonism (CLaSP)

Parkinson's Disease | Late Stage Parkinson's Disease

Netherlands, United Kingdom, Germany, France, Portugal, Sweden
Alnylam Pharmaceuticals

Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

Polyneuropathy | Hereditary Transthyretin-mediated (hATTR) Amyloidosis

Netherlands, Spain, United States, Germany, France, Italy, Portugal
Alnylam Pharmaceuticals

Completed

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

ATTR Amyloidosis | Transthyretin (TTR)-Mediated Amyloidosis | Familial Amyloidotic Polyneuropathy (FAP) | Familial Amyloid Neuropathies

France, Germany, Portugal, United Kingdom, Sweden, Spain
Sanofi

Completed

Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients

Obesity | Eating Disorders

United States, France, Netherlands, Portugal, Sweden, Switzerland, Finland
Dr. Yaacov Lawrence

Completed

Celiac Plexus Radio-Surgery for Pain Management

Pain | Advanced Cancer | Pancreas Cancer

United States, Israel, Portugal, Canada
Novo Nordisk A/S

Completed

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal (PICT2RE)

Diabetes Mellitus, Type 2

Portugal
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (STEP UP)

Obesity

United States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia

Clinical Trials on Sports Nutrition in Portugal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations